Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,547.03
(
-0.90%
)
US TECH 100
23,454.40
(
-1.12%
)
Dow Jones
45,750.77
(
-0.59%
)
Brent Oil
107.22
(
2.67%
)
Bitcoin
69,684.01
(
-0.31%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: poorgradstudent post# 87043

Tuesday, 02/02/2010 3:04:54 PM

Tuesday, February 02, 2010 3:04:54 PM

Post# of 257262
Carfilzomib Development Strategy:

Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma

http://www.onyx-pharm.com/view.cfm/658/Onyx-Pharmaceuticals-Announces-Agreement-with-the-FDA-on-a-Special-Protocol-Assessment-for-Planned-Phase-3-Carfilzomib-Combination-Trial-in-Relapsed-Multiple-Myeloma-
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today